Claudia Isabella Graef

Title: Innovations of Claudia Isabella Graef

Introduction

Claudia Isabella Graef is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of integrin receptor ligands. With a total of three patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

Claudia's latest patents include innovative compounds that bind to integrin receptors. The first patent focuses on novel compounds that serve as ligands for the αβ integrin receptor, detailing their use and the pharmaceutical preparations that incorporate these compounds. The second patent also addresses integrin receptor ligands, emphasizing their preparation, therapeutic applications, and the inclusion of these compounds in pharmaceutical formulations alongside other active ingredients.

Career Highlights

Claudia is currently employed at Abbott GmbH & Co. KG, where she continues to advance her research and development efforts. Her work at Abbott has allowed her to collaborate with leading experts in the field, further enhancing her contributions to pharmaceutical innovations.

Collaborations

Some of Claudia's notable coworkers include Andreas Kling and Udo Lange. Their collaborative efforts have fostered a productive environment for innovation and research.

Conclusion

Claudia Isabella Graef's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patents on integrin receptor ligands highlight her commitment to advancing medical science and improving therapeutic options.